Parexel International Corp (PRXL)

59.23
0.49 0.83
NASDAQ : Health Care
Prev Close 58.74
Open 58.84
Day Low/High 58.50 / 59.42
52 Wk Low/High 56.00 / 76.17
Volume 258.96K
Avg Volume 771.70K
Exchange NASDAQ
Shares Outstanding 53.27M
Market Cap 3.12B
EPS 2.90
P/E Ratio 18.82
Div & Yield N.A. (N.A)

Latest News

PAREXEL International To Participate In Evercore ISI MedTools Conference

PAREXEL International To Participate In Evercore ISI MedTools Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be attending the Evercore ISI MedTools Conference in Boston.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of PAREXEL International Corporation

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of PAREXEL International Corporation

Levi & Korsinsky announces it has commenced an investigation of PAREXEL International Corporation (NASDAQ: PRXL) ("PAREXEL") concerning possible violations of federal securities laws by the Company and/or certain of its...

PAREXEL Launches IDMP-Focused Software And Service Solution

PAREXEL Launches IDMP-Focused Software And Service Solution

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched an Identification of Medicinal Products (IDMP)-focused solution for biopharmaceutical companies.

EQUITY ALERT: Goldberg Law PC Announces An Investigation Of Claims Against PAREXEL International Corporation And Advises Investors With Losses To Contact The Firm

EQUITY ALERT: Goldberg Law PC Announces An Investigation Of Claims Against PAREXEL International Corporation And Advises Investors With Losses To Contact The Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating PAREXEL International Corporation ("PAREXEL" or the "Company") (Nasdaq: PRXL) concerning possible violations of federal...

INVESTOR LOSS ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against PAREXEL International Corporation - PRXL

INVESTOR LOSS ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against PAREXEL International Corporation - PRXL

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of PAREXEL International Corporation (NASDAQ:PRXL) resulting from allegations that...

3 Small Cap Stocks Worth Considering

3 Small Cap Stocks Worth Considering

The market's minnows are swimming away from its whales as the Russell 2000 Index is up about 8% compared with the 5% gain in the S&P 500.

PAREXEL International Reports First Quarter Fiscal Year 2017 Results And Announces New Share Repurchase Program

PAREXEL International Reports First Quarter Fiscal Year 2017 Results And Announces New Share Repurchase Program

PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the first quarter of Fiscal Year 2017, which ended on September 30, 2016.

PAREXEL International To Present At Credit Suisse Healthcare Conference

PAREXEL International To Present At Credit Suisse Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Credit Suisse Healthcare Conference in Phoenix, AZ.

3 Small Cap Stocks Which Could be Worth Snapping Up

3 Small Cap Stocks Which Could be Worth Snapping Up

Parexel, G-III and Quaker Chemical are small caps to watch as the market's minnows outswim its whales.

Short Interest Increases 16% For PRXL

Short Interest Increases 16% For PRXL

The most recent short interest data has been released for the 09/30/2016 settlement date, which shows a 556,464 share increase in total short interest for PAREXEL International Corp. , to 4,007,342, an increase of 16.13% since 09/15/2016.

PAREXEL International Announces Date Of First Quarter Fiscal Year 2017 Earnings Release And Conference Call

PAREXEL International Announces Date Of First Quarter Fiscal Year 2017 Earnings Release And Conference Call

PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for First Quarter Fiscal Year 2017 on Wednesday, October 26, 2016 after the close of the stock market.

PAREXEL Launches Active Tracking Service For Monitoring And Managing Temperature-Controlled Investigational Medicinal Products

PAREXEL Launches Active Tracking Service For Monitoring And Managing Temperature-Controlled Investigational Medicinal Products

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced the launch of its Active Tracking service.

PAREXEL Announces Execution Of Definitive Agreement To Acquire ExecuPharm

PAREXEL Announces Execution Of Definitive Agreement To Acquire ExecuPharm

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that the Company has entered into a definitive agreement to acquire ExecuPharm, Inc.

Christian Dreger Joins PAREXEL As Senior Vice President, PAREXEL Access And PAREXEL Consulting. (Photo: Business Wire)

Christian Dreger Joins PAREXEL As Senior Vice President, PAREXEL Access And PAREXEL Consulting. (Photo: Business Wire)

PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization, today announced the appointment of Christian Dreger, Ph.

PAREXEL International To Present At Wells Fargo Healthcare Conference

PAREXEL International To Present At Wells Fargo Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today it will be presenting at the Wells Fargo Healthcare Conference on Wednesday September 7, 2016 in Boston.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of PAREXEL International Corporation

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of PAREXEL International Corporation

Levi & Korsinsky announces it has commenced an investigation of PAREXEL International Corporation (NASDAQ:PRXL) ("PAREXEL") concerning possible violations of federal securities laws by the Company and/or certain of its...

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against PAREXEL International Corporation - PRXL

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against PAREXEL International Corporation - PRXL

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of PAREXEL International Corporation (NASDAQ:PRXL) resulting from allegations that...

Ubavka DeNoble, MD, Corporate Vice President, PAREXEL, Named By PharmaVOICE As One Of The 100 Most Inspiring People In The Life Sciences Industry. (Photo: Business Wire)

Ubavka DeNoble, MD, Corporate Vice President, PAREXEL, Named By PharmaVOICE As One Of The 100 Most Inspiring People In The Life Sciences Industry. (Photo: Business Wire)

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that PharmaVOICE magazine selected Ubavka DeNoble, MD, Corporate Vice President, as one of the 100...

PAREXEL International Reports Fourth Quarter And Fiscal Year 2016 Results

PAREXEL International Reports Fourth Quarter And Fiscal Year 2016 Results

PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the fourth quarter and Fiscal Year 2016, which ended on June 30, 2016.

Joshua Schultz, Senior Vice President, Worldwide Head Of PAREXEL Access (Photo: Business Wire)

Joshua Schultz, Senior Vice President, Worldwide Head Of PAREXEL Access (Photo: Business Wire)

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the appointment of four company executives to its senior-most leadership team, the Business Review...